Executive summary
The Vaccine Development and Evaluation Centre (VDEC) facilitates the development and evaluation of new vaccines and therapeutics.
VDEC developed an immunoassay at speed during the 2022 global Mpox outbreak that was used to assess serological markers in individuals that have received the Smallpox vaccine and individuals infected with Mpox (formerly known as Monkeypox).
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
